Monsanto’s smear merchant, the Genetic Literacy Project, is now Bayer’s bully
By Jonathan Matthews,
GMWatch
| 08. 31. 2022
Recently the Genetic Literacy Project has been heavily targeting critics of the herbicide Roundup, now owned by Bayer, with a barrage of articles, podcasts, and tweets, in which the controversial University of Florida scientist Kevin Folta has been much to the fore.
It all started when the Guardian published a piece by the award-winning journalist Carey Gillam on a CDC study showing the prevalence in urine samples in the US of Roundup’s controversial active ingredient glyphosate, which has been linked to cancer.
Kevin Folta led the charge for the GLP with a piece that labelled the Guardian article the latest example of “yellow journalism” (i.e. lurid, sensationalist reporting), not to mention “deceptive journalism”, by “scientifically illiterate journalists”. Folta then gave over a further three paragraphs to attacking Gillam personally and outlining his version of her “ethically questionable history”. This somehow failed to mention that, among other things, she won a Society of Environmental Journalists’ book award or that her former colleagues at Reuters say she is “an exceptional journalist” who produces “impeccably reported” stories.
“Slimeball tactics”
The GLP, which has...
Related Articles
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...